FDA Approves Lilly's Zepbound KwikPen for Weight Management

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly's Zepbound KwikPen for weight management, marking an advancement in injectable treatment options delivered via a user-friendly pen device. This approval signifies that the medication has met regulatory standards for safety and efficacy in its indicated use.